Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | IDH1 | O75874 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | PAM | P19021 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7327835 | 0.86 | ALDH1A1 (0.44) | ALDH1A1TSHRCYP2A6MAOBIDH1 | |
| Styrene SCHEMBL364050 | 0.82 | ALDH1A1 (0.74) | ALDH1A1TSHRCYP2A6MAOBIDH1 | |
| Styrene SCHEMBL20153440 | 0.82 | ALDH1A1 (0.74) | ALDH1A1TSHRCYP2A6MAOBIDH1 | |
| Styrene SCHEMBL17644283 | 0.80 | ALDH1A1 (0.70) | ALDH1A1TSHRCYP2A6MAOBIDH1 | |
| SCHEMBL87669 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TSHRCYP2A6MAOBLMNA | |
| SCHEMBL245276 | 0.77 | ALDH1A1 (0.43) | ALDH1A1TSHRCYP2A6MAOBLMNA | |
| SCHEMBL9530439 | 0.76 | SIGMAR1 (0.47) | ALDH1A1TSHRMAOBL3MBTL1MEN1 | |
| SCHEMBL3256288 | 0.76 | SIGMAR1 (0.47) | ALDH1A1TSHRMAOBL3MBTL1MEN1 | |
| SCHEMBL8735737 | 0.76 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL8154332 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TSHRCYP2A6MAOBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115838368-B | Hydroxamic acid compound and derivative thereof, preparation method, pharmaceutical composition and application | 中国药科大学 | 2024-02-27 | — | — | CN | claimed |
| CN-115838368-A | Oxime acid compound and derivative, preparation method, pharmaceutical composition and application thereof | 中国药科大学 | 2023-03-24 | — | — | CN | claimed |
| CN-115838368-B | Hydroxamic acid compound and derivative thereof, preparation method, pharmaceutical composition and application | 中国药科大学 | 2024-02-27 | — | — | CN | disclosed |
| CN-115838368-A | Oxime acid compound and derivative, preparation method, pharmaceutical composition and application thereof | 中国药科大学 | 2023-03-24 | — | — | CN | disclosed |
| EP-1505156-B1 | Process for the enantioselective preparation of secondary alcohols by lipase catalysed solvolysis of the corresponding acetoacetic acid ester | CONSORTIUM ELEKTROCHEM IND (DE) | 2005-12-07 | — | — | EP | disclosed |
| US-20050032182-A1 | Process for the enantioselective preparation of secondary alcohols by lipase-catalyzed solvolysis of the corresponding acetoacetic esters | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH | 2005-02-10 | — | — | US | disclosed |
| EP-1505156-A1 | Process for the enantioselective preparation of secondary alcohols by lipase catalysed solvolysis of the corresponding acetoacetic acid ester | Consortium für elektrochemische Industrie GmbH (DE) | 2005-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050032182-A1 | Process for the enantioselective preparation of secondary alcohols by lipase-catalyzed solvolysis of the corresponding acetoacetic esters | LIPC, LIPE, LIPA | ALDH1A1 187/4885TSHR 2333/4885CYP2A6 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.